Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07686094 · ClinicalTrials.gov registry record · Phase 1
Placental Cells for Diabetic Foot Ulcers
A Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Not yet
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT07686094 is a Phase 1 study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 12 participants.
The verdict
NCT07686094, a Phase 1 study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this research study is to test the safety of placental stem cells to treat non-healing diabetic foot ulcers.
Interventions
- DRUG Placenta Stem Cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2026-10 |
| Est. Completion | 2028-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07686094
The ClinicalTrials.gov registry entry for NCT07686094 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Placenta Stem Cells is the first listed.
NCT07686094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07686094 about?
NCT07686094 is a clinical study titled "Placental Cells for Diabetic Foot Ulcers". The purpose of this research study is to test the safety of placental stem cells to treat non-healing diabetic foot ulcers.
What is the current status of trial NCT07686094?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2026-10. Estimated completion is 2028-12.
What interventions are being tested in trial NCT07686094?
The interventions under investigation include: Placenta Stem Cells (DRUG).
Who is sponsoring clinical trial NCT07686094?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.